Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New bombesin analogues from Biomeasure

Nov. 29, 1996

New market introduction for antiestrogen

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Human brain-derived protein kinase offered for licensing

Nov. 26, 1996

Interim clinical results with Ansan's cancer product

Nov. 22, 1996

New target for drug-resistant tumors identified

Nov. 22, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...